Shaw T
School of Biological Sciences, La Trobe University, Bundoora, Vic., Australia.
Mutat Res. 1988 Jul-Aug;200(1-2):67-97. doi: 10.1016/0027-5107(88)90073-5.
In higher vertebrates, different types of blood cells develop from common precursors. Mammals are unique in possessing two types of blood cells--erythrocytes and platelets--which lack nuclei. Although platelets display consistent and easily-recognisable morphological and ultrastructural characteristics and show extreme metabolic and functional versatility, they are not true cells, being produced by fragmentation of giant polyploid precursors called megakaryocytes. At present, the physiological mechanisms which regulate megakaryocyte development and platelet production are not well understood. Platelets are actively involved in metabolism of purine derivatives and a significant platelet role in pyrimidine metabolism has also been demonstrated (see previous papers). Here an attempt is made to integrate information about platelet involvement in nucleic acid precursor metabolism with current concepts of haematopoiesis, particularly megakaryocyte development and platelet production. It is concluded (i) that megakaryocytic cells are immediate descendents of haematopoietic stem cells which have become polyploid as a result of genetic damage or metabolic imbalances, (ii) megakaryocytes and platelets are the ultimate regulators of stem cell development because they control the availability of thymidine and (iii) that the production of megakaryocytes and platelets is a physiological safety mechanism which prevents fixation of genetic damage and protects other cells from potentially cytotoxic and genotoxic stimuli.
在高等脊椎动物中,不同类型的血细胞由共同的前体细胞发育而来。哺乳动物的独特之处在于拥有两种无细胞核的血细胞——红细胞和血小板。尽管血小板具有一致且易于识别的形态和超微结构特征,并展现出极其多样的代谢和功能,但它们并非真正的细胞,而是由称为巨核细胞的巨大多倍体前体细胞破碎产生的。目前,调节巨核细胞发育和血小板生成的生理机制尚未完全明了。血小板积极参与嘌呤衍生物的代谢,并且在嘧啶代谢中血小板的重要作用也已得到证实(见前文)。在此,我们试图将有关血小板参与核酸前体代谢的信息与当前的造血概念,尤其是巨核细胞发育和血小板生成的概念相结合。得出的结论是:(i)巨核细胞是造血干细胞的直接后代,由于遗传损伤或代谢失衡而变成多倍体;(ii)巨核细胞和血小板是干细胞发育的最终调节者,因为它们控制着胸苷的可用性;(iii)巨核细胞和血小板的生成是一种生理安全机制,可防止遗传损伤的固定,并保护其他细胞免受潜在的细胞毒性和基因毒性刺激。